Latest in Prevention

  • Updates from the Teplizumab Trial: You’re Not Going to Believe the Results

    June 15, 2020

    Last year, at the American Association for Diabetes (ADA) Scientific Sessions, a drug, called teplizumab, was able to significantly delay—for over two...

  • Dr. Jane Buckner Discusses Hydroxychloroquine T1D Prevention Study

    May 28, 2020

    Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.

  • A Promising (Preclinical) Vaccine for Type 1 Diabetes

    May 7, 2020

    Wouldn’t it be nice if you could take a vaccine in infancy, and type 1 diabetes would not develop? Preclinical research suggests it might not be that far away.

  • Dr. Carla Greenbaum Talks about T1D TrialNet During the COVID-19 Pandemic

    May 7, 2020

    Carla Greenbaum, M.D., chair of TrialNet—an international JDRF-supported network that is dedicated to finding cures for type 1 diabetes (T1D)—and a professor...

  • Europe Supports Autoantibodies as Biomarkers for T1D

    April 28, 2020

    It was 2015—five years ago—that three organizations (JDRF, the Endocrine Society and the American Diabetes Association) published a statement urging the adoption...

  • National DNA Day!

    April 24, 2020

    JDRF is honored to celebrate National DNA Day, to commemorate the day in 1953 when the structure of DNA was published. We...

  • In-Home Test Kits Make Screening Convenient and Easy

    April 21, 2020

    TrialNet—an international JDRF-supported network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams dedicated to finding cures for type 1 diabetes...

  • Strengthening Type 1 Diabetes Science by Building Careers

    March 24, 2020

    Sometimes, the funding that JDRF can provide for researchers is exactly the invitation they need to get into the field of type...

  • Universal Screening for Type 1 Diabetes: Its Time has Come?

    January 28, 2020

    Universal screening for type 1 diabetes (T1D) is a priority for JDRF, but the cost versus benefits remain unclear. Now, a large-scale...